Literature DB >> 19885290

A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.

Yoshinori Onuki1, Upkar Bhardwaj, Fotios Papadimitrakopoulos, Diane J Burgess.   

Abstract

In recent years, a variety of devices (drug-eluting stents, artificial organs, biosensors, catheters, scaffolds for tissue engineering, heart valves, etc.) have been developed for implantation into patients. However, when such devices are implanted into the body, the body can react to these in a number of different ways. These reactions can result in an unexpected risk for patients. Therefore, it is important to assess and optimize the biocompatibility of implantable devices. To date, numerous strategies have been investigated to overcome body reactions induced by the implantation of devices. This review focuses on the foreign body response and the approaches that have been taken to overcome this. The biological response following device implantation and the methods for biocompatibility evaluation are summarized. Then the risks of implantable devices and the challenges to overcome these problems are introduced. Specifically, the challenges used to overcome the functional loss of glucose sensors, restenosis after stent implantation, and calcification induced by implantable devices are discussed.

Entities:  

Keywords:  biocompatibility; calcification; foreign body reaction; glucose sensor; implantable device; stent

Year:  2008        PMID: 19885290      PMCID: PMC2769826          DOI: 10.1177/193229680800200610

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  145 in total

Review 1.  Performance of subcutaneously implanted glucose sensors for continuous monitoring.

Authors:  M Gerritsen; J A Jansen; J A Lutterman
Journal:  Neth J Med       Date:  1999-04       Impact factor: 1.422

2.  Biomaterial calcification without direct material-cell interaction.

Authors:  V I Shumakov; I B Rosanova; S L Vasin; L A Salomatina; V I Sevastianov
Journal:  ASAIO Trans       Date:  1990 Jul-Sep

Review 3.  Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems.

Authors:  J M Anderson; J J Langone
Journal:  J Control Release       Date:  1999-02-01       Impact factor: 9.776

4.  Application of a combination of neutral red and amido black staining for rapid, reliable cytotoxicity testing of biomaterials.

Authors:  G Ciapetti; D Granchi; E Verri; L Savarino; D Cavedagna; A Pizzoferrato
Journal:  Biomaterials       Date:  1996-07       Impact factor: 12.479

Review 5.  Fibrogenic cytokines: the role of immune mediators in the development of scar tissue.

Authors:  E J Kovacs
Journal:  Immunol Today       Date:  1991-01

6.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

7.  Biocompatibility evaluation of hydroxyapatite/collagen nanocomposites doped with Zn+2.

Authors:  M H Santos; P Valerio; A M Goes; M F Leite; L G D Heneine; H S Mansur
Journal:  Biomed Mater       Date:  2007-05-03       Impact factor: 3.715

8.  In vivo nitric oxide sensor using non-conducting polymer-modified carbon fiber.

Authors:  J K Park; P H Tran; J K Chao; R Ghodadra; R Rangarajan; N V Thakor
Journal:  Biosens Bioelectron       Date:  1998-11-15       Impact factor: 10.618

9.  Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy.

Authors:  T P Johnston; E L Bove; S F Bolling; F J Schoen; J A Boyd; G Golomb; R J Levy
Journal:  ASAIO Trans       Date:  1988 Jul-Sep

10.  Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  R G Macdonald; R S Panush; C J Pepine
Journal:  Am J Cardiol       Date:  1987-07-31       Impact factor: 2.778

View more
  82 in total

1.  Evaluating the clinical accuracy of GlucoMen®Day: a novel microdialysis-based continuous glucose monitor.

Authors:  Francesco Valgimigli; Fausto Lucarelli; Cosimo Scuffi; Sara Morandi; Iolanda Sposato
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Short-term and long-term effects of orthopedic biodegradable implants.

Authors:  Ami R Amini; James S Wallace; Syam P Nukavarapu
Journal:  J Long Term Eff Med Implants       Date:  2011

Review 3.  Technologies for continuous glucose monitoring: current problems and future promises.

Authors:  Santhisagar Vaddiraju; Diane J Burgess; Ioannis Tomazos; Faquir C Jain; Fotios Papadimitrakopoulos
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

4.  Prevascularized silicon membranes for the enhancement of transport to implanted medical devices.

Authors:  Kristan S Worthington; Luke A Wiley; Robert F Mullins; Budd A Tucker; Eric Nuxoll
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-08-28       Impact factor: 3.368

5.  BCNU/PLGA microspheres: a promising strategy for the treatment of gliomas in mice.

Authors:  Tongming Zhu; Yiwen Shen; Qisheng Tang; Luping Chen; Huasong Gao; Jianhong Zhu
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

6.  Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.

Authors:  Jie Shen; Diane J Burgess
Journal:  Int J Pharm       Date:  2011-10-13       Impact factor: 5.875

Review 7.  Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

Authors:  Wei Chen; Bryant C Yung; Zhiyong Qian; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

8.  Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer.

Authors:  Divya Sharma; Jagdish Singh
Journal:  J Control Release       Date:  2020-04-10       Impact factor: 9.776

9.  Injectable cellulose-based hydrogels as nucleus pulposus replacements: Assessment of in vitro structural stability, ex vivo herniation risk, and in vivo biocompatibility.

Authors:  Huizi Anna Lin; Devika M Varma; Warren W Hom; Michelle A Cruz; Philip R Nasser; Robert G Phelps; James C Iatridis; Steven B Nicoll
Journal:  J Mech Behav Biomed Mater       Date:  2019-04-17

10.  Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.

Authors:  Mayura Oak; Jagdish Singh
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.